Norwegian Startup Genetic Analysis to Offer Array-Based Microbiota Screening

According to CEO Morten Isaksen, a number of diseases are thought to be linked to an imbalance in the microbial profile of the gut, including inflammatory bowel disease, necrotizing enterocolitis, allergies, and autism.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.